Codice QR

Efficacy evaluation of a new oral chewable tablet containing fluralaner, moxidectin, and pyrantel (BRAVECTO® TriUNO) against hookworm and Toxascaris leonina infections in a non-terminal study design in dogs

Abstract Background Broad-spectrum combination products with efficacy against endo- and ectoparasites offer the potential to optimize owner adherence to expert recommendations for canine antiparasitic treatments. In the development program for a chewable tablet containing fluralaner, moxidectin, and...

Descrizione completa

Salvato in:
Autori principali: Lea Heinau, Ivo Petersen, Nadja Rohdich, Claudia Plehn, Rafael Chiummo, Eva Zschiesche, Luther van der Mescht, Julian Liebenberg, Anne Barrett
Natura: Artigo
Lingua:Inglês
Pubblicazione: BMC 2026-02-01
Serie:Parasites & Vectors
Soggetti:
Ancylostoma caninum
Canine
Dog
Fluralaner
Hookworm
Moxidectin
Accesso online:https://doi.org/10.1186/s13071-025-07232-w
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi